DTIL
NASDAQ · Biotechnology
Precision Biosciences Inc
$7.94
-0.10 (-1.24%)
Open$8.11
Previous Close$8.04
Day High$8.17
Day Low$7.80
52W High$9.62
52W Low$3.53
Volume—
Avg Volume201.8K
Market Cap292.21M
P/E Ratio—
EPS$-2.80
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+286.5% upside
Current
$7.94
$7.94
Target
$30.69
$30.69
$21.79
$30.69 avg
$37.55
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 78.45M | 70.72M | 15.69M |
| Net Income | -104,692,550 | -84,939,416 | 557.5K |
| Profit Margin | -133.5% | -126.8% | 3.6% |
| EBITDA | -116,122,419 | -99,446,766 | 726.6K |
| Free Cash Flow | — | — | 441.5K |
| Rev Growth | +10.9% | +10.9% | -7.6% |
| Debt/Equity | 0.24 | 0.24 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $294.45 | -0.18% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $467.06 | -0.22% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $167.95 | -1.05% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $542.62 | -0.81% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $951.19 | -0.86% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $156.65 | -2.00% | 7.7 | 20.98B |